Related references
Note: Only part of the references are listed.Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance
Luis Manso et al.
PLOS ONE (2016)
Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes
Rachel Barrow-McGee et al.
NATURE COMMUNICATIONS (2016)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Metal ion and ligand binding of integrin α5β1
Wei Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
β1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma
W. Shawn Carbonell et al.
CANCER RESEARCH (2013)
Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
Arman Jahangiri et al.
CLINICAL CANCER RESEARCH (2013)
Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model
Parul Gupta et al.
PLOS ONE (2013)
Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
Yao Dai et al.
BMC CANCER (2012)
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Kan V. Lu et al.
CANCER CELL (2012)
Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy
Michael Delay et al.
CLINICAL CANCER RESEARCH (2012)
Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor
Masamichi Nagae et al.
JOURNAL OF CELL BIOLOGY (2012)
Neurosurgical Management and Prognosis of Patients With Glioblastoma That Progresses During Bevacizumab Treatment
Aaron J. Clark et al.
NEUROSURGERY (2012)
High-Dose Antiangiogenic Therapy for Glioblastoma: Less May Be More.?
John F. de Groot
CLINICAL CANCER RESEARCH (2011)
Quantitative proteomics of the integrin adhesome show a myosin II-dependent recruitment of LIM domain proteins
Herbert B. Schiller et al.
EMBO REPORTS (2011)
Biochemical, Proteomic, Structural, and Thermodynamic Characterizations of Integrin-linked Kinase (ILK) CROSS-VALIDATION OF THE PSEUDOKINASE
Koichi Fukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
Keith W. Rickert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
A. K. Mitra et al.
ONCOGENE (2011)
Integrin-linked kinase: Not so 'pseudo' after all
G. E. Hannigan et al.
ONCOGENE (2011)
Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of Caveolae
Sara A. Wickstroem et al.
DEVELOPMENTAL CELL (2010)
Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
Gur Pines et al.
FEBS LETTERS (2010)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Vascular Basement Membrane as Soil'' in Brain Metastasis
W. Shawn Carbonell et al.
PLOS ONE (2009)
Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels
Marie-Astrid Herve et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
β1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts
Catherine C. Park et al.
CANCER RESEARCH (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Detecting protein-protein interactions by far western blotting
Yuliang Wu et al.
NATURE PROTOCOLS (2007)
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Chun-Chi Liang et al.
NATURE PROTOCOLS (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
ILK, PINCH and parvin: the tIPP of integrin signalling
KR Legate et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Integrin-linked kinase: A cancer therapeutic target unique among its ILK
G Hannigan et al.
NATURE REVIEWS CANCER (2005)
A method for simultaneous alignment of multiple protein structures
M Shatsky et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
VEGF165b, an inhibitory vascular endothelial growth factor splice variant:: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
J Woolard et al.
CANCER RESEARCH (2004)
Activation and inhibition of mast cells degranulation affect their morphometric parameters
F Levi-Schaffer et al.
LIFE SCIENCES (2000)
Share Paper
